Global Vaccines Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Vaccines market size is predicted to grow from US$ 49350 million in 2025 to US$ 69260 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
LP Information, Inc. (LPI) ' newest research report, the “Vaccines Industry Forecast” looks at past sales and reviews total world Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines sales for 2025 through 2031. With Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Vaccines market?
What factors are driving Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines market opportunities vary by end market size?
How does Vaccines break out by Type, by Application?
The global Vaccines market size is predicted to grow from US$ 49350 million in 2025 to US$ 69260 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and 'remember' it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
LP Information, Inc. (LPI) ' newest research report, the “Vaccines Industry Forecast” looks at past sales and reviews total world Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Vaccines sales for 2025 through 2031. With Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccines.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccines market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- Rabies vaccine
- Influenza vaccine
- HPV vaccine
- Hepatitis B
- Hepatitis A
- Leprosy vaccine
- Polio vaccine
- JE vaccine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi
- Merck
- Pfizer
- Novartis(GSK)
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
- Jintan
What is the 10-year outlook for the global Vaccines market?
What factors are driving Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccines market opportunities vary by end market size?
How does Vaccines break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccines Sale Price by Type (2020-2025)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccines Revenue by Company (2020-2025)
3.2.2 Global Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 AMERICAS
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2020-2025)
5.1.2 Americas Vaccines Revenue by Country (2020-2025)
5.2 Americas Vaccines Sales by Type (2020-2025)
5.3 Americas Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2020-2025)
6.1.2 APAC Vaccines Revenue by Region (2020-2025)
6.2 APAC Vaccines Sales by Type (2020-2025)
6.3 APAC Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2020-2025)
7.1.2 Europe Vaccines Revenue by Country (2020-2025)
7.2 Europe Vaccines Sales by Type (2020-2025)
7.3 Europe Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 WORLD FORECAST REVIEW FOR VACCINES BY GEOGRAPHIC REGION
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2026-2031)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccines Forecast by Type (2026-2031)
12.7 Global Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Portfolios and Specifications
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Portfolios and Specifications
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Portfolios and Specifications
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Portfolios and Specifications
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Portfolios and Specifications
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Portfolios and Specifications
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Vaccines Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2020, 2024 & 2031
2.2 Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Vaccines Sales by Type
2.3.1 Global Vaccines Sales Market Share by Type (2020-2025)
2.3.2 Global Vaccines Revenue and Market Share by Type (2020-2025)
2.3.3 Global Vaccines Sale Price by Type (2020-2025)
2.4 Vaccines Segment by Application
2.4.1 Rabies vaccine
2.4.2 Influenza vaccine
2.4.3 HPV vaccine
2.4.4 Hepatitis B
2.4.5 Hepatitis A
2.4.6 Leprosy vaccine
2.4.7 Polio vaccine
2.4.8 JE vaccine
2.4.9 Others
2.5 Vaccines Sales by Application
2.5.1 Global Vaccines Sale Market Share by Application (2020-2025)
2.5.2 Global Vaccines Revenue and Market Share by Application (2020-2025)
2.5.3 Global Vaccines Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Vaccines Breakdown Data by Company
3.1.1 Global Vaccines Annual Sales by Company (2020-2025)
3.1.2 Global Vaccines Sales Market Share by Company (2020-2025)
3.2 Global Vaccines Annual Revenue by Company (2020-2025)
3.2.1 Global Vaccines Revenue by Company (2020-2025)
3.2.2 Global Vaccines Revenue Market Share by Company (2020-2025)
3.3 Global Vaccines Sale Price by Company
3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccines Product Location Distribution
3.4.2 Players Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Vaccines Market Size by Geographic Region (2020-2025)
4.1.1 Global Vaccines Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Vaccines Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Vaccines Market Size by Country/Region (2020-2025)
4.2.1 Global Vaccines Annual Sales by Country/Region (2020-2025)
4.2.2 Global Vaccines Annual Revenue by Country/Region (2020-2025)
4.3 Americas Vaccines Sales Growth
4.4 APAC Vaccines Sales Growth
4.5 Europe Vaccines Sales Growth
4.6 Middle East & Africa Vaccines Sales Growth
5 AMERICAS
5.1 Americas Vaccines Sales by Country
5.1.1 Americas Vaccines Sales by Country (2020-2025)
5.1.2 Americas Vaccines Revenue by Country (2020-2025)
5.2 Americas Vaccines Sales by Type (2020-2025)
5.3 Americas Vaccines Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccines Sales by Region
6.1.1 APAC Vaccines Sales by Region (2020-2025)
6.1.2 APAC Vaccines Revenue by Region (2020-2025)
6.2 APAC Vaccines Sales by Type (2020-2025)
6.3 APAC Vaccines Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Vaccines by Country
7.1.1 Europe Vaccines Sales by Country (2020-2025)
7.1.2 Europe Vaccines Revenue by Country (2020-2025)
7.2 Europe Vaccines Sales by Type (2020-2025)
7.3 Europe Vaccines Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Vaccines by Country
8.1.1 Middle East & Africa Vaccines Sales by Country (2020-2025)
8.1.2 Middle East & Africa Vaccines Revenue by Country (2020-2025)
8.2 Middle East & Africa Vaccines Sales by Type (2020-2025)
8.3 Middle East & Africa Vaccines Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccines
10.3 Manufacturing Process Analysis of Vaccines
10.4 Industry Chain Structure of Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccines Distributors
11.3 Vaccines Customer
12 WORLD FORECAST REVIEW FOR VACCINES BY GEOGRAPHIC REGION
12.1 Global Vaccines Market Size Forecast by Region
12.1.1 Global Vaccines Forecast by Region (2026-2031)
12.1.2 Global Vaccines Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Vaccines Forecast by Type (2026-2031)
12.7 Global Vaccines Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Vaccines Product Portfolios and Specifications
13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Vaccines Product Portfolios and Specifications
13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Novartis(GSK)
13.5.1 Novartis(GSK) Company Information
13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis(GSK) Main Business Overview
13.5.5 Novartis(GSK) Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Vaccines Product Portfolios and Specifications
13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Vaccines Product Portfolios and Specifications
13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Vaccines Product Portfolios and Specifications
13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
13.14 Jintan
13.14.1 Jintan Company Information
13.14.2 Jintan Vaccines Product Portfolios and Specifications
13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jintan Main Business Overview
13.14.5 Jintan Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales byType (2020-2025) & (K Units)
Table 8. Global Vaccines Sales Market Share byType (2020-2025)
Table 9. Global Vaccines Revenue byType (2020-2025) & ($ million)
Table 10. Global Vaccines Revenue Market Share byType (2020-2025)
Table 11. Global Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Vaccines Sale by Application (2020-2025) & (K Units)
Table 13. Global Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2020-2025) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vaccines Sales by Country (2020-2025) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vaccines Sales byType (2020-2025) & (K Units)
Table 39. Americas Vaccines Sales by Application (2020-2025) & (K Units)
Table 40. APAC Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. APAC Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vaccines Sales byType (2020-2025) & (K Units)
Table 44. APAC Vaccines Sales by Application (2020-2025) & (K Units)
Table 45. Europe Vaccines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vaccines Sales byType (2020-2025) & (K Units)
Table 48. Europe Vaccines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Vaccines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vaccines Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Vaccines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Vaccines
Table 54. Key Market Challenges & Risks of Vaccines
Table 55. Key IndustryTrends of Vaccines
Table 56. Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccines Distributors List
Table 59. Vaccines Customer List
Table 60. Global Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. GSK Vaccines Product Portfolios and Specifications
Table 76. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Vaccines Product Portfolios and Specifications
Table 81. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Vaccines Product Portfolios and Specifications
Table 86. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Vaccines Product Portfolios and Specifications
Table 91. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 96. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis(GSK) Main Business
Table 98. Novartis(GSK) Latest Developments
Table 99. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Vaccines Product Portfolios and Specifications
Table 101. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. CSL Main Business
Table 103. CSL Latest Developments
Table 104. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 106. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. MedImmune LLC Main Business
Table 108. MedImmune LLC Latest Developments
Table 109. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 111. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. J&J(Crucell) Main Business
Table 113. J&J(Crucell) Latest Developments
Table 114. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. China National Biotec Vaccines Product Portfolios and Specifications
Table 116. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. China National Biotec Main Business
Table 118. China National Biotec Latest Developments
Table 119.Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120.Tiantan Vaccines Product Portfolios and Specifications
Table 121.Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122.Tiantan Main Business
Table 123.Tiantan Latest Developments
Table 124. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Vaccines Product Portfolios and Specifications
Table 126. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hualan Main Business
Table 128. Hualan Latest Developments
Table 129. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Kangtai Vaccines Product Portfolios and Specifications
Table 131. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kangtai Main Business
Table 133. Kangtai Latest Developments
Table 134. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. Hissen Vaccines Product Portfolios and Specifications
Table 136. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Hissen Main Business
Table 138. Hissen Latest Developments
Table 139. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Jintan Vaccines Product Portfolios and Specifications
Table 141. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Jintan Main Business
Table 143. Jintan Latest Developments
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales byType (2020-2025) & (K Units)
Table 8. Global Vaccines Sales Market Share byType (2020-2025)
Table 9. Global Vaccines Revenue byType (2020-2025) & ($ million)
Table 10. Global Vaccines Revenue Market Share byType (2020-2025)
Table 11. Global Vaccines Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Vaccines Sale by Application (2020-2025) & (K Units)
Table 13. Global Vaccines Sale Market Share by Application (2020-2025)
Table 14. Global Vaccines Revenue by Application (2020-2025) & ($ million)
Table 15. Global Vaccines Revenue Market Share by Application (2020-2025)
Table 16. Global Vaccines Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2020-2025) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2020-2025)
Table 19. Global Vaccines Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Vaccines Revenue Market Share by Company (2020-2025)
Table 21. Global Vaccines Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Vaccines Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2020-2025)
Table 29. Global Vaccines Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Vaccines Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2020-2025)
Table 33. Global Vaccines Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Vaccines Sales by Country (2020-2025) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2020-2025)
Table 37. Americas Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Vaccines Sales byType (2020-2025) & (K Units)
Table 39. Americas Vaccines Sales by Application (2020-2025) & (K Units)
Table 40. APAC Vaccines Sales by Region (2020-2025) & (K Units)
Table 41. APAC Vaccines Sales Market Share by Region (2020-2025)
Table 42. APAC Vaccines Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Vaccines Sales byType (2020-2025) & (K Units)
Table 44. APAC Vaccines Sales by Application (2020-2025) & (K Units)
Table 45. Europe Vaccines Sales by Country (2020-2025) & (K Units)
Table 46. Europe Vaccines Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Vaccines Sales byType (2020-2025) & (K Units)
Table 48. Europe Vaccines Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Vaccines Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Vaccines Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Vaccines Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Vaccines Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Vaccines
Table 54. Key Market Challenges & Risks of Vaccines
Table 55. Key IndustryTrends of Vaccines
Table 56. Vaccines Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Vaccines Distributors List
Table 59. Vaccines Customer List
Table 60. Global Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Vaccines RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Vaccines Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Vaccines SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Vaccines Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Vaccines SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Vaccines RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Vaccines SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Vaccines RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Vaccines SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Vaccines RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 75. GSK Vaccines Product Portfolios and Specifications
Table 76. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Main Business
Table 78. GSK Latest Developments
Table 79. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. Sanofi Vaccines Product Portfolios and Specifications
Table 81. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Sanofi Main Business
Table 83. Sanofi Latest Developments
Table 84. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Merck Vaccines Product Portfolios and Specifications
Table 86. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Merck Main Business
Table 88. Merck Latest Developments
Table 89. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Pfizer Vaccines Product Portfolios and Specifications
Table 91. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Pfizer Main Business
Table 93. Pfizer Latest Developments
Table 94. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 96. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis(GSK) Main Business
Table 98. Novartis(GSK) Latest Developments
Table 99. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. CSL Vaccines Product Portfolios and Specifications
Table 101. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. CSL Main Business
Table 103. CSL Latest Developments
Table 104. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 105. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 106. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. MedImmune LLC Main Business
Table 108. MedImmune LLC Latest Developments
Table 109. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 110. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 111. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. J&J(Crucell) Main Business
Table 113. J&J(Crucell) Latest Developments
Table 114. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 115. China National Biotec Vaccines Product Portfolios and Specifications
Table 116. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. China National Biotec Main Business
Table 118. China National Biotec Latest Developments
Table 119.Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 120.Tiantan Vaccines Product Portfolios and Specifications
Table 121.Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122.Tiantan Main Business
Table 123.Tiantan Latest Developments
Table 124. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 125. Hualan Vaccines Product Portfolios and Specifications
Table 126. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Hualan Main Business
Table 128. Hualan Latest Developments
Table 129. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 130. Kangtai Vaccines Product Portfolios and Specifications
Table 131. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kangtai Main Business
Table 133. Kangtai Latest Developments
Table 134. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 135. Hissen Vaccines Product Portfolios and Specifications
Table 136. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Hissen Main Business
Table 138. Hissen Latest Developments
Table 139. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 140. Jintan Vaccines Product Portfolios and Specifications
Table 141. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Jintan Main Business
Table 143. Jintan Latest Developments
LIST OF FIGURES
Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Vaccines
Figure 12. Product Picture of Viral Vaccines
Figure 13. Product Picture of Polysaccharide Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Vaccines Sales Market Share byType in 2025
Figure 16. Global Vaccines Revenue Market Share byType (2020-2025)
Figure 17. Vaccines Consumed in Rabies vaccine
Figure 18. Global Vaccines Market: Rabies vaccine (2020-2025) & (K Units)
Figure 19. Vaccines Consumed in Influenza vaccine
Figure 20. Global Vaccines Market: Influenza vaccine (2020-2025) & (K Units)
Figure 21. Vaccines Consumed in HPV vaccine
Figure 22. Global Vaccines Market: HPV vaccine (2020-2025) & (K Units)
Figure 23. Vaccines Consumed in Hepatitis B
Figure 24. Global Vaccines Market: Hepatitis B (2020-2025) & (K Units)
Figure 25. Vaccines Consumed in Hepatitis A
Figure 26. Global Vaccines Market: Hepatitis A (2020-2025) & (K Units)
Figure 27. Vaccines Consumed in Leprosy vaccine
Figure 28. Global Vaccines Market: Leprosy vaccine (2020-2025) & (K Units)
Figure 29. Vaccines Consumed in Polio vaccine
Figure 30. Global Vaccines Market: Polio vaccine (2020-2025) & (K Units)
Figure 31. Vaccines Consumed in JE vaccine
Figure 32. Global Vaccines Market: JE vaccine (2020-2025) & (K Units)
Figure 33. Vaccines Consumed in Others
Figure 34. Global Vaccines Market: Others (2020-2025) & (K Units)
Figure 35. Global Vaccines Sale Market Share by Application (2024)
Figure 36. Global Vaccines Revenue Market Share by Application in 2025
Figure 37. Vaccines Sales by Company in 2025 (K Units)
Figure 38. Global Vaccines Sales Market Share by Company in 2025
Figure 39. Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 42. Global Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Vaccines Sales 2020-2025 (K Units)
Figure 44. Americas Vaccines Revenue 2020-2025 ($ millions)
Figure 45. APAC Vaccines Sales 2020-2025 (K Units)
Figure 46. APAC Vaccines Revenue 2020-2025 ($ millions)
Figure 47. Europe Vaccines Sales 2020-2025 (K Units)
Figure 48. Europe Vaccines Revenue 2020-2025 ($ millions)
Figure 49. Middle East & Africa Vaccines Sales 2020-2025 (K Units)
Figure 50. Middle East & Africa Vaccines Revenue 2020-2025 ($ millions)
Figure 51. Americas Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Vaccines Revenue Market Share by Country (2020-2025)
Figure 53. Americas Vaccines Sales Market Share byType (2020-2025)
Figure 54. Americas Vaccines Sales Market Share by Application (2020-2025)
Figure 55. United States Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Canada Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Mexico Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. Brazil Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. APAC Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Vaccines Revenue Market Share by Region (2020-2025)
Figure 61. APAC Vaccines Sales Market Share byType (2020-2025)
Figure 62. APAC Vaccines Sales Market Share by Application (2020-2025)
Figure 63. China Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Japan Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. South Korea Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Southeast Asia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. India Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Australia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. ChinaTaiwan Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Europe Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Vaccines Revenue Market Share by Country (2020-2025)
Figure 72. Europe Vaccines Sales Market Share byType (2020-2025)
Figure 73. Europe Vaccines Sales Market Share by Application (2020-2025)
Figure 74. Germany Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75.France Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. UK Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. Italy Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Russia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 79. Middle East & Africa Vaccines Sales Market Share by Country (2020-2025)
Figure 80. Middle East & Africa Vaccines Sales Market Share byType (2020-2025)
Figure 81. Middle East & Africa Vaccines Sales Market Share by Application (2020-2025)
Figure 82. Egypt Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 83. South Africa Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 84. Israel Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 85.Turkey Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 86. GCC Countries Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Vaccines in 2025
Figure 88. Manufacturing Process Analysis of Vaccines
Figure 89. Industry Chain Structure of Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Vaccines Sales MarketForecast by Region (2026-2031)
Figure 92. Global Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 93. Global Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 94. Global Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 95. Global Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 96. Global Vaccines Revenue Market ShareForecast by Application (2026-2031)
Figure 1. Picture of Vaccines
Figure 2. Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Vaccines Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Vaccines Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Vaccines Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Vaccines Sales Market Share by Country/Region (2024)
Figure 10. Vaccines Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Recombinant Vaccines
Figure 12. Product Picture of Viral Vaccines
Figure 13. Product Picture of Polysaccharide Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Vaccines Sales Market Share byType in 2025
Figure 16. Global Vaccines Revenue Market Share byType (2020-2025)
Figure 17. Vaccines Consumed in Rabies vaccine
Figure 18. Global Vaccines Market: Rabies vaccine (2020-2025) & (K Units)
Figure 19. Vaccines Consumed in Influenza vaccine
Figure 20. Global Vaccines Market: Influenza vaccine (2020-2025) & (K Units)
Figure 21. Vaccines Consumed in HPV vaccine
Figure 22. Global Vaccines Market: HPV vaccine (2020-2025) & (K Units)
Figure 23. Vaccines Consumed in Hepatitis B
Figure 24. Global Vaccines Market: Hepatitis B (2020-2025) & (K Units)
Figure 25. Vaccines Consumed in Hepatitis A
Figure 26. Global Vaccines Market: Hepatitis A (2020-2025) & (K Units)
Figure 27. Vaccines Consumed in Leprosy vaccine
Figure 28. Global Vaccines Market: Leprosy vaccine (2020-2025) & (K Units)
Figure 29. Vaccines Consumed in Polio vaccine
Figure 30. Global Vaccines Market: Polio vaccine (2020-2025) & (K Units)
Figure 31. Vaccines Consumed in JE vaccine
Figure 32. Global Vaccines Market: JE vaccine (2020-2025) & (K Units)
Figure 33. Vaccines Consumed in Others
Figure 34. Global Vaccines Market: Others (2020-2025) & (K Units)
Figure 35. Global Vaccines Sale Market Share by Application (2024)
Figure 36. Global Vaccines Revenue Market Share by Application in 2025
Figure 37. Vaccines Sales by Company in 2025 (K Units)
Figure 38. Global Vaccines Sales Market Share by Company in 2025
Figure 39. Vaccines Revenue by Company in 2025 ($ millions)
Figure 40. Global Vaccines Revenue Market Share by Company in 2025
Figure 41. Global Vaccines Sales Market Share by Geographic Region (2020-2025)
Figure 42. Global Vaccines Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Vaccines Sales 2020-2025 (K Units)
Figure 44. Americas Vaccines Revenue 2020-2025 ($ millions)
Figure 45. APAC Vaccines Sales 2020-2025 (K Units)
Figure 46. APAC Vaccines Revenue 2020-2025 ($ millions)
Figure 47. Europe Vaccines Sales 2020-2025 (K Units)
Figure 48. Europe Vaccines Revenue 2020-2025 ($ millions)
Figure 49. Middle East & Africa Vaccines Sales 2020-2025 (K Units)
Figure 50. Middle East & Africa Vaccines Revenue 2020-2025 ($ millions)
Figure 51. Americas Vaccines Sales Market Share by Country in 2025
Figure 52. Americas Vaccines Revenue Market Share by Country (2020-2025)
Figure 53. Americas Vaccines Sales Market Share byType (2020-2025)
Figure 54. Americas Vaccines Sales Market Share by Application (2020-2025)
Figure 55. United States Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 56. Canada Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 57. Mexico Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 58. Brazil Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 59. APAC Vaccines Sales Market Share by Region in 2025
Figure 60. APAC Vaccines Revenue Market Share by Region (2020-2025)
Figure 61. APAC Vaccines Sales Market Share byType (2020-2025)
Figure 62. APAC Vaccines Sales Market Share by Application (2020-2025)
Figure 63. China Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 64. Japan Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 65. South Korea Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 66. Southeast Asia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 67. India Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 68. Australia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 69. ChinaTaiwan Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 70. Europe Vaccines Sales Market Share by Country in 2025
Figure 71. Europe Vaccines Revenue Market Share by Country (2020-2025)
Figure 72. Europe Vaccines Sales Market Share byType (2020-2025)
Figure 73. Europe Vaccines Sales Market Share by Application (2020-2025)
Figure 74. Germany Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 75.France Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 76. UK Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 77. Italy Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 78. Russia Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 79. Middle East & Africa Vaccines Sales Market Share by Country (2020-2025)
Figure 80. Middle East & Africa Vaccines Sales Market Share byType (2020-2025)
Figure 81. Middle East & Africa Vaccines Sales Market Share by Application (2020-2025)
Figure 82. Egypt Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 83. South Africa Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 84. Israel Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 85.Turkey Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 86. GCC Countries Vaccines Revenue Growth 2020-2025 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Vaccines in 2025
Figure 88. Manufacturing Process Analysis of Vaccines
Figure 89. Industry Chain Structure of Vaccines
Figure 90. Channels of Distribution
Figure 91. Global Vaccines Sales MarketForecast by Region (2026-2031)
Figure 92. Global Vaccines Revenue Market ShareForecast by Region (2026-2031)
Figure 93. Global Vaccines Sales Market ShareForecast byType (2026-2031)
Figure 94. Global Vaccines Revenue Market ShareForecast byType (2026-2031)
Figure 95. Global Vaccines Sales Market ShareForecast by Application (2026-2031)
Figure 96. Global Vaccines Revenue Market ShareForecast by Application (2026-2031)
